JAZZ vs XTIA · P/E 1988, rev $4.07B vs rev $3.2M
Jazz Pharmaceuticals PLC (JAZZ) versus XTI Aerospace, Inc. (XTIA) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
XTI Aerospace, Inc. (XTIA) is a aerospace & defense company listed on NASDAQ.
Latest reported JAZZ revenue for 2024-12-31 was $4.07B. Net income was $560.1M. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported XTIA revenue for 2024-12-31 was $3.2M. Net income was -$35.6M. Revenue was down 29.8% from 2023-12-31 to 2024-12-31. XTIA currently screens at market cap $69.3M.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. XTIA currently screens at market cap $69.3M.
Not investment advice. Open the JAZZ and XTIA stock pages for the full models.
Not investment advice.